If you have been searching through the ICD-10-CM manual, you know it can feel like a maze. You might have landed on the code C79.11 and wondered: Is this the right code for my patient? Does this mean breast cancer? What is the difference between this and a primary tumor?
Let us clear up the confusion right away.
ICD-10 code C79.11 stands for Secondary malignant neoplasm of the breast. In simpler terms, this code is used when cancer that started somewhere else in the body (like the lung, skin, or ovary) has spread (metastasized) to the breast tissue.
This is not primary breast cancer. This is an important distinction that affects everything from treatment plans to insurance reimbursements.
In this guide, we will walk through everything you need to know about C79.11. We will cover real-life coding scenarios, common mistakes to avoid, how it differs from other breast-related codes, and practical tips for medical coders and healthcare professionals.
What Exactly Does ICD-10 Code C79.11 Mean?
To understand C79.11, it helps to break down the code structure.
- C79 : Secondary malignant neoplasm of other and unspecified sites
- .11 : Specific site – Breast
So, C79.11 sits inside a larger category of codes for cancers that have spread. When a doctor documents “metastatic cancer to the breast” or “secondary breast malignancy,” this is the code they are likely looking for.
Key Definition
C79.11: Secondary malignant neoplasm of the breast. Use this code when the breast is not the original location of the cancer.
A Quick Example
Imagine a patient who had melanoma on their back five years ago. Today, a biopsy of a new lump in the breast shows melanoma cells. The primary cancer (origin) is the skin. The breast is the secondary site. You would code:
- Primary site: C43.9 (Malignant melanoma of skin, unspecified)
- Secondary site: C79.11 (Secondary malignant neoplasm of breast)
Does that make sense? Good. Now let us look at why this distinction is so important.
Primary vs. Secondary Breast Malignancy: A Vital Difference
This is the single most common area of confusion. Let us compare them side by side.
| Feature | Primary Breast Cancer | Secondary Breast Cancer (C79.11) |
|---|---|---|
| Origin | Started in the breast tissue | Started elsewhere (lung, colon, ovary, skin, etc.) |
| Cell type | Breast tissue cells (ductal, lobular) | Cells from the original cancer (e.g., lung cells) |
| Treatment | Surgery, radiation, breast-specific chemo | Systemic therapy targeting the primary cancer type |
| Prognosis | Varies by stage | Usually advanced/stage IV disease |
| ICD-10 code | C50.x (e.g., C50.911) | C79.11 |
Why does this matter for coding?
Using the wrong code can lead to:
- Denied insurance claims
- Incorrect treatment pathways
- Flawed cancer registry data
- Delayed reimbursement for the provider
Important Note for Coders: Always confirm with the pathology report. The report will state the histology (cell type). If the report says “adenocarcinoma of lung origin” but the tumor is in the breast, you need C79.11, not a C50 code.
Clinical Scenarios Where C79.11 Is Used
Let us move from theory to real life. Here are common situations where you would assign C79.11.
Scenario 1: Lung Cancer Metastasis to the Breast
A 62-year-old woman has a history of non-small cell lung cancer (NSCLC). During a follow-up PET scan, a new lesion appears in her left breast. Biopsy confirms NSCLC cells. There is no primary breast cancer.
- Primary code: C34.90 (Malignant neoplasm of unspecified part of unspecified bronchus or lung)
- Secondary code: C79.11
Scenario 2: Ovarian Cancer Spreading to the Breast
A 55-year-old patient with Stage IV ovarian cancer reports a new breast lump. Imaging and biopsy confirm metastatic ovarian cancer to the breast.
- Primary code: C56.9 (Malignant neoplasm of unspecified ovary)
- Secondary code: C79.11
Scenario 3: Malignant Melanoma to the Breast
A 40-year-old man with a history of malignant melanoma on his back develops a subcutaneous nodule in his right breast. Pathology: metastatic melanoma.
- Primary code: C43.9 (Malignant melanoma of skin, unspecified)
- Secondary code: C79.11
Scenario 4: Unknown Primary Site
Sometimes, a patient presents with a breast mass. The biopsy shows cancer, but the pathologist cannot determine the origin. The workup finds no primary breast cancer. This is rare but possible.
- Code: C79.11 (since it is a secondary site, even if the primary is unknown)
- Additional code: C80.1 (Malignant (primary) neoplasm, unspecified) – only if truly unknown after full workup.
Official Coding Guidelines for C79.11
Following official ICD-10-CM guidelines is non-negotiable. Here are the key rules for using C79.11.
Guideline 1: Sequence of Codes
When a patient is seen for treatment of a secondary site, the secondary malignancy is coded first if that is the reason for the encounter. However, if the patient is receiving active treatment for the primary cancer, the primary code is sequenced first.
Example: Patient receiving chemotherapy for lung cancer. She also has a known secondary breast deposit, but today’s visit is for lung cancer treatment.
- First: C34.90 (Lung cancer)
- Second: C79.11 (Secondary breast)
Example: Patient comes in specifically for a biopsy of the breast metastasis.
- First: C79.11 (Secondary breast)
- Second: C34.90 (Lung cancer)
Guideline 2: Do Not Use for Recurrent Primary Breast Cancer
If a patient had breast cancer in the past, was treated, and now a new breast mass appears that is the same type of breast cancer (e.g., recurrent ductal carcinoma), do not use C79.11. Use the appropriate recurrent breast cancer code (Z85.3 for history, plus C50.x for recurrence).
Guideline 3: Use with Z51 Codes (Encounter for Treatment)
If the patient is receiving chemotherapy, radiation, or immunotherapy specifically for the secondary breast lesion, add a Z51 code.
- Z51.11 – Encounter for antineoplastic chemotherapy
- Z51.0 – Encounter for radiation therapy
Complete List of Official Exclusions for C79.11
The ICD-10 manual is very specific about what cannot be coded with C79.11. Here are the official exclusions.
| Exclusion Code | Description | Why it is separate |
|---|---|---|
| C50.xxx | Malignant neoplasm of breast (primary) | Different origin, different treatment |
| D05.xx | Carcinoma in situ of breast | Not invasive; pre-cancerous stage |
| D24.9 | Benign neoplasm of breast | Non-cancerous; completely different |
| C79.2 | Secondary malignant neoplasm of skin | Different site entirely |
| C79.31 | Secondary malignant neoplasm of brain | Different site entirely |
| C78.xx | Secondary malignant neoplasm of respiratory/digestive organs | Different body system |
A Crucial Distinction: C79.81 vs. C79.11
Do not confuse C79.11 with C79.81 (Secondary malignant neoplasm of the breast of the opposite side? No – that is not correct). Actually, let us clarify:
- C79.11 : Secondary malignant neoplasm of breast (unspecified which breast, or both)
- There is no separate code for “left” or “right” secondary breast. But if laterality is documented, you can add a laterality modifier in some coding systems, or just use C79.11 with a note.
What about C79.8? That is for secondary malignant neoplasm of other specified sites (like the heart or lymph nodes – but note: secondary breast is C79.11, so do not use C79.8 for breast).
How to Document for C79.11 (Advice for Physicians)
Doctors, your documentation drives accurate coding. Here is what coders need you to include to justify the use of C79.11.
Required elements in your note:
- Statement of metastatic disease: “This is a metastasis from [primary site].”
- Location: “Right breast, upper outer quadrant.”
- Histology confirmation: “Biopsy confirms [cell type] consistent with primary [site].”
- Treatment plan: “We will treat this as a secondary breast lesion with systemic therapy directed at the primary cancer.”
Sample dictation:
“The patient is a 58-year-old female with a known history of renal cell carcinoma, status post nephrectomy three years ago. She now presents with a firm, painless mass in the left breast. Ultrasound-guided biopsy was performed, and pathology demonstrates clear cell carcinoma, consistent with renal origin. There is no evidence of primary breast cancer. This represents secondary malignant neoplasm of the breast (C79.11) . We will initiate sunitinib for metastatic renal cell carcinoma to the breast.”
That kind of note makes a coder’s job easy.
Common Coding Errors and How to Avoid Them
Even experienced coders make mistakes. Here are the most frequent errors with C79.11.
Error 1: Confusing C79.11 with C50.9
- Mistake: Coding a lung metastasis to the breast as C50.9 (primary breast cancer).
- Consequence: The patient is incorrectly labeled as having primary breast cancer. This leads to wrong staging, wrong treatment (mastectomy instead of systemic therapy), and skewed cancer statistics.
- Fix: Always check the pathology report for cell origin.
Error 2: Forgetting the Primary Code
- Mistake: Only coding C79.11 and leaving out the primary malignancy code.
- Consequence: Incomplete medical record. The payer does not know where the cancer started.
- Fix: Always list the primary site code first, unless the encounter is solely for the secondary site (and even then, list it second).
Error 3: Using C79.11 for Contralateral Recurrence
- Mistake: A patient had right breast cancer. Now, a new primary is found in the left breast. Coder uses C79.11.
- Consequence: Incorrect classification. This is a new primary breast cancer, not a metastasis.
- Fix: Use a new C50 code for the left breast, plus Z85.3 for history of right breast cancer.
Error 4: Not Using Laterality When Available
- Mistake: Only coding C79.11 without specifying which breast.
- Consequence: Loss of clinical data.
- Fix: While ICD-10-CM does not have separate laterality for C79.11, use a modifier (in some software) or add a free-text note: “secondary malignant neoplasm, left breast.”
The Link Between C79.11 and Staging
Understanding staging helps you grasp why this code matters clinically.
- Stage IV cancer means the cancer has spread from its original site to distant organs.
- A secondary malignant neoplasm in the breast automatically makes the cancer Stage IV (distant metastasis).
Examples of common primary cancers that spread to the breast:
- Lung cancer
- Melanoma (skin)
- Ovarian cancer
- Colon cancer
- Renal cell carcinoma (kidney)
- Uterine cancer
- Sarcomas (rare)
Did you know? Secondary breast tumors are rare. They account for only about 0.5% to 2% of all breast malignancies. But when they occur, they change the entire treatment approach.
Treatment Implications (For Clinical Understanding)
Why does C79.11 change treatment? Because you are not treating “breast cancer.” You are treating, for example, lung cancer that happens to be in the breast.
Primary Breast Cancer (C50.x) Treatment:
- Lumpectomy or mastectomy
- Sentinel lymph node biopsy
- Radiation to the breast
- Hormonal therapy (if ER/PR positive)
- HER2-targeted therapy
Secondary Breast Cancer (C79.11) Treatment:
- No mastectomy (unless for palliation)
- No sentinel lymph node biopsy
- Systemic chemotherapy based on the primary tumor
- Immunotherapy (if primary tumor type responds)
- Targeted therapy (e.g., for kidney or lung cancer)
Real-world example:
A woman with ovarian cancer that spreads to her breast will receive platinum-based chemotherapy (for ovarian cancer), not tamoxifen (for breast cancer).
As a coder, you are not expected to know treatments. But understanding the logic helps you spot documentation gaps.
Billing and Reimbursement Tips for C79.11
Insurance companies scrutinize cancer codes. Here is how to ensure clean claims.
Medical Necessity
For C79.11 to be payable, the service (e.g., biopsy, imaging, chemotherapy) must be medically necessary for a secondary malignancy.
Common Covered Services:
- Biopsy of breast lesion (CPT 19081, 19083, etc.) – covered when C79.11 is the diagnosis.
- PET/CT scan (CPT 78815) – covered for staging of metastatic disease.
- Chemotherapy administration (CPT 96413) – covered when linked to C79.11 plus primary code.
Denial Risk:
If you only bill C79.11 without a primary site code, some payers may deny the claim, arguing “unknown primary” or “insufficient documentation.”
Best Practice:
Always link the following on your claim:
- ICD-10 primary (e.g., C34.90)
- ICD-10 secondary (C79.11)
- Procedure code (e.g., biopsy or chemo)
- Modifier (if needed, e.g., -25 for significant separately identifiable E/M)
Complete List of Related ICD-10 Codes
For your reference, here are codes that are often used alongside or instead of C79.11.
| Code | Description | Relationship to C79.11 |
|---|---|---|
| C50.011 | Malignant neoplasm of nipple and areola, right female breast | Primary site – do not use together unless two separate primaries |
| C50.912 | Malignant neoplasm of unspecified site of left female breast | Primary site |
| C79.81 | Secondary malignant neoplasm of breast (this is actually a duplicate – wait, careful!) | Correction: There is only one code for secondary breast: C79.11. C79.81 is for secondary malignant neoplasm of other specified sites like the heart, not breast. |
| Z85.3 | Personal history of malignant neoplasm of breast | Use for history of primary breast cancer |
| Z80.3 | Family history of malignant neoplasm of breast | Family history, not patient’s own diagnosis |
| R92.8 | Other abnormal finding on diagnostic imaging of breast | Use before biopsy confirms cancer |
| D48.60 | Neoplasm of uncertain behavior of unspecified breast | Not malignant; different category |
Frequently Asked Questions (FAQ)
Here are answers to the most common questions about ICD-10 code C79.11.
1. Is C79.11 the same as breast cancer?
No. C79.11 means cancer from another part of the body has spread to the breast. It is not primary breast cancer.
2. Can I use C79.11 if the patient has no history of cancer?
Yes, but rarely. Sometimes the primary cancer is discovered after the breast metastasis. In that case, code the secondary (C79.11) first, then the primary once known.
3. Does C79.11 require a laterality (left or right) code?
ICD-10-CM does not have separate laterality codes for C79.11. However, documentation should specify which breast. You can use a placeholder or note the laterality in the medical record.
4. How do I code a patient who has both a primary breast cancer and a secondary breast cancer from another site?
This is extremely rare but possible. For example, a patient with primary breast cancer (C50.9) and a separate lung cancer metastasis to the other breast. You would code both:
- C50.9 (primary breast)
- C79.11 (secondary from lung)
- C34.90 (primary lung)
5. What if the pathology report says “consistent with breast primary”?
Then you do not use C79.11. Use the appropriate C50 code for primary breast cancer.
6. Is C79.11 used for male breast cancer?
Yes, if the secondary malignant neoplasm occurs in a male breast. C79.11 is not gender-specific. However, primary male breast cancer has its own codes (C50.x with laterality).
7. How do I code a secondary breast neoplasm that has been surgically removed?
Once excised, use the same C79.11 code. The code describes the condition, not the treatment status. Add a Z98.8 (other specified postprocedural states) if needed, but usually C79.11 remains active.
Real-World Coding Workflows
Let us walk through a typical coder’s day with C79.11.
Workflow Example A: Outpatient Oncology Clinic
Encounter: Patient with history of colon cancer, new breast mass.
Documentation: “Biopsy confirms metastatic adenocarcinoma, consistent with colon primary.”
Coder action:
- Verify pathology report.
- Sequence: Primary first (C18.9 – Malignant neoplasm of colon), then secondary (C79.11).
- Add encounter code: Z51.11 if chemo given.
- Submit claim.
Workflow Example B: Inpatient Hospital Stay
Encounter: Patient admitted for shortness of breath. Known history of melanoma with secondary breast lesions (C79.11). Now, new brain metastases found.
Documentation: “Admission for dyspnea. Stage IV melanoma with mets to breast and brain.”
Coder action:
- Principal diagnosis: R06.02 (Shortness of breath) – reason for admission.
- Secondary diagnoses:
- C43.9 (Melanoma, primary)
- C79.11 (Secondary breast)
- C79.31 (Secondary brain)
- Follow sequencing guidelines (the condition that caused the admission goes first).
Important Notes for Medical Coders and Billers
Keep these points in mind every time you consider C79.11.
- ✅ Do confirm histology before coding.
- ✅ Do sequence primary site first, unless the encounter is specifically for the secondary site.
- ✅ Do educate physicians when documentation is vague (“breast mass” is not enough; need “metastatic”).
- ❌ Do not assume a breast mass in a cancer patient is secondary. It could be a new primary.
- ❌ Do not use C79.11 for breast recurrence of a previous primary breast cancer.
- ❌ Do not forget to update the problem list in the EHR. Secondary malignancies should be listed separately.
Additional Resources and Link
For further reading and official updates, we recommend the following trusted source:
🔗 Additional Resource:
CMS ICD-10-CM Official Guidelines for Coding and Reporting
(Always refer to the current year’s guidelines. The link above takes you to the CMS page where you can download the full PDF.)
You can also consult the American Academy of Professional Coders (AAPC) code lookup tool for real-time code verification.
Conclusion
Let us summarize this guide in three clear lines:
- ICD-10 code C79.11 is used exclusively for secondary malignant neoplasm of the breast – cancer that spread to the breast from another primary site, not primary breast cancer.
- Accurate coding requires confirming histology via pathology report, sequencing the primary site first, and avoiding common errors like confusing C79.11 with C50 codes.
- Proper use of C79.11 ensures correct staging (Stage IV), appropriate treatment planning, and clean insurance claims.
Keep this guide handy. Bookmark the CMS resource. And always remember: when in doubt, look at the pathology report. That single document holds the truth about origin.
Thank you for reading, and happy coding.
*Disclaimer: This article is for educational purposes only and does not constitute legal, medical, or billing advice. ICD-10 codes and guidelines change annually. Always refer to the most current official ICD-10-CM manual and consult with a certified medical coder or compliance officer for specific cases.*
